Altering the trajectory of HIV in Europe
Author
Abstract
Suggested Citation
Download full text from publisher
References listed on IDEAS
- Marta Trapero-Bertran & Juan Oliva-Moreno, 2014. "Economic impact of HIV/AIDS: a systematic review in five European countries," Health Economics Review, Springer, vol. 4(1), pages 1-16, December.
- repec:plo:pmed00:1002690 is not listed on IDEAS
- Fumiyo Nakagawa & Alec Miners & Colette J Smith & Ruth Simmons & Rebecca K Lodwick & Valentina Cambiano & Jens D Lundgren & Valerie Delpech & Andrew N Phillips, 2015. "Projected Lifetime Healthcare Costs Associated with HIV Infection," PLOS ONE, Public Library of Science, vol. 10(4), pages 1-12, April.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Parastu Kasaie & Matthew Radford & Sunaina Kapoor & Younghee Jung & Beatriz Hernandez Novoa & David Dowdy & Maunank Shah, 2018. "Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain," PLOS ONE, Public Library of Science, vol. 13(11), pages 1-15, November.
- Osvaldo Ulises Garay & Marie Libérée Nishimwe & Marwân-al-Qays Bousmah & Asmaa Janah & Pierre-Marie Girard & Geneviève Chêne & Laetitia Moinot & Luis Sagaon-Teyssier & Jean-Luc Meynard & Bruno Spire &, 2019. "Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)," PharmacoEconomics - Open, Springer, vol. 3(4), pages 505-515, December.
- Raquel J. Fonseca & Luísa Cunha, 2020. "A net present value approach to health insurance choice," Decisions in Economics and Finance, Springer;Associazione per la Matematica, vol. 43(2), pages 709-724, December.
- Lucrezia Ferrario & Barbara Menzaghi & Giuliano Rizzardini & Alessandro Roccia & Elisabetta Garagiola & Daniele Bellavia & Fabrizio Schettini & Emanuela Foglia, 2025. "From Clinical to Non-clinical Outcomes in the Treatment of HIV: An Economic and Organizational Impact Assessment," PharmacoEconomics - Open, Springer, vol. 9(2), pages 313-326, March.
More about this item
Keywords
;JEL classification:
- I1 - Health, Education, and Welfare - - Health
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ohe:conres:002507. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Publications Manager The email address of this maintainer does not seem to be valid anymore. Please ask Publications Manager to update the entry or send us the correct address (email available below). General contact details of provider: https://edirc.repec.org/data/ohecouk.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.
Printed from https://ideas.repec.org/p/ohe/conres/002507.html